Response to "Quantitative analysis of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of llcer method using gadobenate dimeglumine as contrast agent"
- PMID: 28580722
- DOI: 10.1002/jmri.25788
Response to "Quantitative analysis of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of llcer method using gadobenate dimeglumine as contrast agent"
Comment on
-
Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.J Magn Reson Imaging. 2015 Nov;42(5):1249-58. doi: 10.1002/jmri.24897. Epub 2015 Apr 6. J Magn Reson Imaging. 2015. PMID: 25851028
-
Quantitative analysis Of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of LLCER method using gadobenate dimeglumine as contrast agent.J Magn Reson Imaging. 2018 Mar;47(3):860-861. doi: 10.1002/jmri.25789. Epub 2017 Jun 6. J Magn Reson Imaging. 2018. PMID: 28589549 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
